Goodwin-Led Biotech Tops 3 IPOs Totaling $384M
Rubius Therapeutics Inc., which is raising money to develop therapies based on red blood cells, raised $241 million in an upsized initial public offering advised by Goodwin Procter LLP, the biggest...To view the full article, register now.
Already a subscriber? Click here to view full article